Investigation Overview
July 16, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Par Pharmaceutical Companies, Inc. (NYSE:PRX) shares was announced concerning whether the offer to acquire Par Pharmaceutical Companies, Inc. and the takeover process are unfair to investors in NYSE:PRX shares. The investigation by a law firm concerns whether certain officers and directors of Par Ph...
You must register (for free) or login to view the entire investigation.